Tauroursodeoxycholic acid
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Tauroursodeoxycholic acid Product Information
Tauroursodeoxycholic acid is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Ursodeoxycholic. The product is supplied by Clearsynth under CAT No. CS-O-02519.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Tauroursodeoxycholic acid
CAS No.
14605-22-2
CAT No.
CS-O-02519
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C26H45NO6S
Molecular Weight
499.70
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Tauroursodeoxycholic acid is supplied with detailed characterization data compliant with regulatory guideline. Tauroursodeoxycholic acid can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Ursodeoxycholic.
Overview
"Tauroursodeoxycholic acid is being investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis."
Synonyms
Tauroursodeoxycholic acid
Application Notes
"Tauroursodeoxycholic acid is being investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.